Academies Weekend includes compounding and long-term-care pharmacists with top-notch programming and beautiful surroundings. This year, the Academy of Pharmacy Owners will be attending and participating with a pharmacy owner education track!  

Long Term Care Track – September 27-28, 2014
Join us for the weekend and earn 9 CE hours on:

  • Dispensing Controlled Substances* - September 27 (8:45am - 10:15am)
    [ + ] View Course Description [ - ]

    Presented by: DEA Representative
    This session will cover the Drug Enforcement Administration (DEA) policies on controlled substance dispensing.

  • Medicine Donation: Making Destruction Obsolete - September 27 (10:30am - 12:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Kiah Williams
    Annually, nearly $1 billion of unused, unexpired medicine is destroyed by the long term care industry. Meanwhile, one in four adults in the U.S. skip medicine they need due to costs. Recent changes to California law make it legal for long term care pharmacies to donate, rather than destroy medications to safety-net clinics. Through a dynamic lecture with time for questions, this session will ensure participants understand these law changes and options to donate. Participants will leave the session able to confidently weigh medicine donation against destruction, and know how to move forward with donation if they are interested.

    Learning objectives for this session include:
    1. Understand the magnitude, costs, and consequences of the volume of unused medicine produced by the long term care industry.

    2. Understand the recent law changes that have made donating unused medicine legal for long-term care pharmacies.

    3. Understand how medicine donation can become feasible and cheaper than destruction.

  • Regulatory Update on LTC - September 27 (1:30pm - 3:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Sue Chaban, PharmD
    This program will provide an overview of pharmaceutical services related federal and state regulations for long-term care facilities. This overview will include: a review of both federal (code of federal regulations) and state (title 22) regulations limited to pharmaceutical services, a discussion of unnecessary drug as related to antipsychotic medication use, a brief discussion of CMS guidance change regarding antipsychotic medication use for BPSD (Behavioral and Psychological symptoms of Dementia), and a step-by-step discussion of CDPH antipsychotic survey tool including informed consent requirements.

    Learning objectives for this session include:

    1. Review of State and Federal Requirements for Pharmaceutical Services

    2. Discuss CDPH “Antipsychotic Use Survey Tool”

    3. Review elements of informed consent for antipsychotic medications

  • Dementia Care - September 27 (3:15pm - 4:45pm)
    [ + ] View Course Description [ - ]

    Presented by: Rebecca Ferrini, MD, MPH
    Behavioral difficulties in dementia reduce quality of life and can be challenging to manage, especially in a complex regulatory environment. Commonly used medications are not approved for this indication and have serious side effects. Although there are trends towards reductions in antipsychotics for this population, use continues—why? How can the pharmacist help assure that symptom management meets the highest standards of practice? The pharmacist can assist in educating the physician with research evidence, and assist in evaluating data specific to the individual. Through clarification of diagnosis, target symptoms, alternatives, and well collected side effect and behavioral data around reductions, the pharmacist can play a key role in improving the rationality of psychoactive medication prescribing.

    Learning objectives for this session include:

    1. State the primary concerns of regulators, patients, families and clinical staff in regards to managing behavioral symptoms in dementia

    2. Be familiar with federal regulations and their requirements in regards to dementia and psychoactive medications

    3. Identify disturbing symptoms in dementia and some possible alternative treatments

    4. Interpret a literature summary on research-based pharmacology for behavioral symptoms in dementia

    5. Review psychoactive regimen, symptoms and diagnoses and provide specific recommendations for quality care

    6. Provide a framework for the safest and most effective manner to reduce psychoactive medications

  • New Drugs - September 28 (8:45am - 10:15am)
    [ + ] View Course Description [ - ]

    Presented by: Dan Hussar, PhD
    This presentation considers the properties and uses of selected new therapeutic agents. The indications and routes of administration for these new drugs are reviewed, as are the most important precautions and practical considerations regarding their use. Where possible, the properties of the new drugs are compared with those of older drugs marketed for the same indications. A New Drug Comparison Rating (NDCR) is provided for each of the new drugs considered.

    Learning objectives for this session include:

    1. Identify the indications and routes of administration of the new therapeutic agents.

    2. Identify the important pharmacokinetic properties and the unique characteristics of the new drugs.

    3. Identify the most important adverse events and precautions of the new drugs.

    4. Compare the new drugs to the older therapeutic agents to which they are most similar in activity.

    5. Identify information regarding the new drugs that should be communicated to patients.

  • Transitions in Care - September 28 (10:30am - 12:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Lee Meyer
    This program is for pharmacists and others caring for residents of skilled nursing facilities. The focus of the program is on practical, everyday issues encountered by facility nursing staff, LTC pharmacists dispensing medications to the residents, and consultant pharmacists that may result in medication related problems for seniors as they transition through various levels of care. Reduction of medication errors and other medication related problems, both clinical and practical, is an appropriate QAPI activity in the SNF that can be coordinated with other levels of care. The influences of regulatory and compliance measures impacting the acute hospitals as well as perspectives from the SNF, the assisted living facility and from home environments will be presented and discussed.

    Learning objectives for this session include:

    1. Identify transition points for residents in LTC

    2. Identify at least 5 actions that can be taken in any nursing home to enhance transitions both in and out of the facility

    3. Describe the regulatory basis of transitions of care

    4. Describe the medication use process changes from acute to skilled to assisted living and to home and,

    5. Identify 5 practical actions that the facility can take to avoid medication errors and related hospital readmissions

Compounders Track – September 27, 2014
Join us on Saturday and earn 6 CE hours on:

  • Accreditation vs. State Licensure (9:15am - 10:15am)
    Sponsored by: Analytical Research Laboratories
    [ + ] View Course Description [ - ]

    This program will address accreditation and licensure. While both processes aim to protect public health and safety, they differ in their approach. The approaches used by licensing bodies such as boards of pharmacy, and accreditation organizations will be compared and contrasted. The program will also address accreditation in home infusion, compounding and specialty pharmacy and the different forces that drive or require organizations to seek accreditation in each segment. The benefits of licensure and accreditation will also be addressed.

    At the conclusion of this program, attendees will:

    • Be able to compare and contrast accreditation and licensure

    • Understand the external factors that drive organizations to seek home infusion, compounding and specialty pharmacy accreditation

    • Understand how market forces may change accreditation in the future

    • Understand the benefits of accreditation for their organization and as perceived by patients, prescribers, payers and government

  • Controlled Substances, For Office Use, LSCs Contracting with Non-LSCs, 3rd Party Marketers, and other Legal Conundrums (10:30am - 12:00pm)
    Sponsored by: PCCA
    [ + ] View Course Description [ - ]

    Presented by: Tony Park, PharmD, J.D.
    Come join Dr. Tony J Park to discuss some of the most perplexing regulatory issues facing compounders today: for office use, out-of-state deliveries, FDCA § 503A/503B, controlled substance compounding, hiring independent marketers, and more.

    Learning objectives for this session include:

    1. Recognize legal allowances for a pharmacy to furnish For Office Use prescription drugs.

    2. Distinguish from unlawful furnishings for office use.

    3. Construct a pharmacy action plan to ensure conformity with all regulations regarding compounded controlled substances.

    4. Identify potential pitfalls caused by hiring independent marketers.

    5. Interpret what is allowed under CA Business & Professions Code § 4123 "Compounding Drug for Other Pharmacy for Parenteral Therapy."

  • Quality is Only an Assumption – Until it is Measured (1:30pm - 3:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Russell Odegard, BS, MBA
    This program is about helping pharmacists understand the key influencers of quality within their pharmacy. It will give them the tools to deconstruct their operations into discrete, easy to understand elements, after which they will be able to rebuild based on current best practices and technologies. It will help them understand, when, where and how to measure for quality, and will conclude by helping them understand how to establish a culture of continuous improvement by leveraging, and gleaning untapped value from data that is generated routinely by the measurement process.

    At the completion of this session, the participant will be able to:

    1. Define quality in terms of what is important to the patient.

    2. List the key influencers, and how they can negatively influence quality.

    3. Discuss an approach to evaluating and modifying your operations to increase the probability of compound the right product, correctly, every time.

    4. List the points in the process of compounding a medication where measurement is critical to understanding what level of quality you actually have.

    5. Understand what it takes to establish a culture of continuous improvement within your operations.

  • Nutraceutical Adjuncts for Improving Chronic Pain Outcomes (3:15pm - 4:45pm)
    Sponsored by: Freedom Pharmaceuticals
    [ + ] View Course Description [ - ]

    Presented by: Mark T. Burger, Pharm.D
    As compounding pharmacists concerned with patient outcomes related to chronic pain we have always been concerned about dose, side effects, cognitive function, pain relief, addiction, legal ramifications of dispensing, and drug-drug interactions. In recent years due to the promotion of topical pain gels/creams and the growing concern for addiction potential of opiates, chronic pain and its alleviation have become an intense therapeutic modality as patients and physicians seek alternatives. Compounders have always stepped up to help clinicians and patients solve these problems and some pain gel combinations are truly innovative. But we may lose sight of the “whole patient” as we focus on multi-actives, insurance reimbursement, patient costs, and physician acceptance. What we may lose sight of in the fray are co-morbidities that impinge upon the patient’s perception of pain. We should ask ourselves if we can step slightly to the side of our compounding per persona to help the patient with these “other” issues: hormone disruptions, glycation effects, peripheral nerve health, sleep, etc. This program explores some of those possibilities.

    Learning objectives for this session:

    1. The attendee will be able to identify at least 3 physiological processes that contribute to the perception and experience of pain by the typical patient.

    2. The attendee will be able to describe the basic processes that contribute to the formation of AGEs (Advanced Glycation End-Products).

    3. The attendee will be able to identify at least 4 co-morbidities of chronic pain and how they contribute to the patient’s experience of pain.

    4. The attendee will be able to cite the 3 hormones and how their levels are affected by chronic pain.

Pharmacy Owners Track – September 27, 2014
Join us on Saturday and earn 6 CE hours on:
  • Specialty Pharmacy: An Increasing Opportunity for Retail Pharmacy (8:45am - 10:15am)
    [ + ] View Course Description [ - ]

    Presented by: Craig Stern, RPh, PharmD, MBA, FASCP, FASHP, FICA, FLMI, FAMCP, FCPhA, CSP
    This presentation will create stimulating discussions and innovative solutions for dealing with effective and accurate Specialty Injectables claims payment. This energetic discussion will include Pricing Solutions, Billing Options, Pricing to Contract Discounts, Estimating price to ASP contracts, and utilization management solutions as a baseline for creating a valuable and useful Specialty Pharmacy program for Retail Pharmacies. Clarification and education of attendees will also focus on the “cornerstones” of an effective Specialty Pharmacy Program focus on key issues affecting timely and appropriate pricing and payment of Specialty Injectables, such as:

    • Effective Specialty Vendor Contracting

    • Pharmacy vs. medical billing

    • Utilization management

    • Thorough understanding of the key principles and “rules” for Specialty Injectable Pricing

  • Communicating with the Difficult Patient or Prescriber (10:30am - 12:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Jody Jacobsen Wedret, RPh, FASHP, FCSHP, BS Pharm.
    September 27
    Effective communication involves listening more than talking. In today's healthcare marketplace, it is imperative that respect be foremost in conversations between patients and their practitioners and practitioner to practitioner. This session will look at breakdowns that happen in communication and fixes. Participants will be given vignettes to work through and present.

    Learning objectives for this session include:

    1. Understand the importance of listening

    2. Be able to separate emotion, emoting and goals from a conversation

    3. Learn ways to steer a conversation to a win-win.

  • Pharmacy Law Update – 2014 Q3 (1:30pm - 3:00pm)
    [ + ] View Course Description [ - ]

    Presented by: Tony J. Park, Pharm.D., J.D.
    September 27
    Come join Dr. Tony J Park to discuss the latest changes in laws pertaining to the practice of pharmacy in California, emphasizing those with potentially far-reaching provisions and examining their real world effects.

    Upon completion, the pharmacist should be able to:

    1. Recognize all new pharmacy laws in California.

    2. Distinguish between old and new rules of pharmacy practice.

    3. Construct a pharmacy action plan to ensure conformity with all new laws.

    4. Identify potential pitfalls caused by the new pharmacy laws.

  • Why Quality Measures Matter (3:15pm - 4:45pm)
    [ + ] View Course Description [ - ]

    Presented by: Nicholas Dorich, PharmD
    Community pharmacy has long been considered the most accessible site for health care delivery. Due to this accessibility and other elements of pharmacy care, pharmacists have frequently championed their level of patient care and how they improve patient care outcomes. Now, pharmacies and health plans have the information and data to better show how pharmacies are impacting patient care. This session will highlight the use of medication safety and adherence measures and how they impact community pharmacies. In addition, we’ll discuss how pharmacies can understand and improve their performance scores.

    Learning objectives for this session include:

    • Describe the reasoning for measuring the quality of medication use

    • Explain how the Star Ratings program related to medication use

    • Evaluate performance strategies related to medication measurement that pharmacies can implement to improve medication use
*Session(s) are tentative


Saturday, September 27
8:00 am - 8:45 am  Registration
8:45 am - 10:15 am  CE Sessions
10:15 am - 10:30 am  Break
10:30 am - 12:00 pm  CE Sessions
12:00 pm - 1:30 pm  Lunch & Exhibits
1:30 pm - 3:00 pm  CE Sessions
3:00 pm - 3:15 pm  Break
3:15 pm - 4:45 pm  CE Sessions
4:45 pm - 6:15 pm  Reception
Sponsored by Medisca

Sunday, September 28
8:00 am - 8:45 am  Registration
8:45 am - 10:15 am  CE Sessions
10:15 am - 10:30 am  Break
10:30 am - 12:00 pm  CE Sessions  

Registration Rates

Early Bird
Rcvd by 9/5/14
Rcvd by 9/19/14
Rcvd after 9/19/14
ONE DAY      
  $99 member
$199 non-member
$119 member
$239 non-member
$139 member
$279 non-member
Pharmacists $229 member
$459 non-member
$249 member
$499 non-member
$269 member
$539 non-member
$149 member
$299 non-member
$169 member
$339 non-member
$189 member
$379 non-member
Pharmacists $299 member
$529 non-member
$319 member
$549 non-member
$339 member
$579 non-member

*Non-members: Save $100 off your member dues by joining today! Contact (916) 779-4524 for more information. 


Cancellations are subject to 30% handling fee, there will be NO REFUNDS issued for cancellations received within 10 business days prior to program. Cancellations must be in writing. Refunds will NOT be made for no-shows. However, substitutions will be allowed. Should CPhA cancel the program, a full registration fee refund will be issued.

To register online,
please select a track below: 
To register by fax or mail, 
please download a registration

Hotel Information

DoubleTree by Hilton Hotel Anaheim - Orange County
100 The City Drive
Orange, California, 92868
Phone: (714) 634-4500
Fax: (714) 978-3839

Room rate: $119/night
For reservations,
call 1-800-HILTONS;
reference CPhA Academies Weekend 2014

You can also make hotel reservations online at:

Deadline for room rate extended until: 
September 1, 2014